Neutrophils use superoxide to control bacterial infection at a distance

PLoS Pathog. 2018 Jul 17;14(7):e1007157. doi: 10.1371/journal.ppat.1007157. eCollection 2018 Jul.

Abstract

Understanding the roles of neutrophils and macrophages in fighting bacterial infections is a critical issue in human pathologies. Although phagocytic killing has been extensively studied, little is known about how bacteria are eliminated extracellularly in live vertebrates. We have recently developed an infection model in the zebrafish embryo in which leukocytes cannot reach the injected bacteria. When Escherichia coli bacteria are injected within the notochord, both neutrophils and macrophages are massively recruited during several days, but do not infiltrate the infected tissue presumably because of its tough collagen sheath. Nevertheless, the bacteria are killed during the first 24 hours, and we report here that neutrophils, but not macrophages are involved in the control of the infection. Using genetic and chemical approaches, we show that even in absence of phagocytosis, the bactericidal action relies on NADPH oxidase-dependent production of superoxide in neutrophils. We thus reveal a host effector mechanism mediated by neutrophils that eliminates bacteria that cannot be reached by phagocytes and that is independent of macrophages, NO synthase or myeloperoxidase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Escherichia coli / immunology
  • Escherichia coli Infections / immunology*
  • Neutrophils / immunology*
  • Superoxides / immunology*
  • Zebrafish

Substances

  • Superoxides

Grants and funding

This work was supported by a grant from the European Community’s Seventh Framework Program (FP7- PEOPLE-2011-ITN) under the Marie-Curie Initial Training Network FishForPharma [grant agreement no. PITN-GA-2011-289209] and by a grant from the European Community’s H2020 Program [Marie-Curie Innovative Training Network ImageInLife: Grant Agreement n° 721537]. QTP has been supported first by FishForPharma, then by Fondation de la Recherche Médicale (FDT20150532259). TS is supported by ImageInLife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.